Trade Mark Journal No.2026/041 9 October 2026

UK00004450492 24 September 2026 (5)

Image for mark UK00004450492
International priority date claimed: 21 September 2026 (United States of America) (50120868)
Class 5
Pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of fibrodysplasia ossificans progressiva; pharmaceutical preparations for the prevention and treatment of heterotopic ossification lesions; pharmaceutical preparations for the treatment of ossification; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of neuropathic pain.

Mirum Pharmaceuticals, Inc.

Representative: Mohun Aldridge Sykes Limited